Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

29.62 +0.36 (+1.23%)

Official Closing Price Updated: 6:30 PM EDT, Aug 24, 2026 Add to My Watchlist

Price and Volume

Volume	1,051,735
Open	29.43
Bid (Size)	29.40 (100)
Ask (Size)	29.75 (100)
Prev. Close	29.26
Today's Range	29.40 - 29.73
52wk Range	28.55 - 38.79
Shares Outstanding	N/A
Dividend Yield	3.25%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics

August 18, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew’s new FLOW FLEXTEND™ COBLATION™ Wand improves access¹* and resection efficiency²** for complex hip procedures vs. fixed-angle options

August 17, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Performance

YTD	-9.9%	-9.9%
1 Month	-3.1%	-3.1%
3 Month	-2.7%	-2.7%
6 Month	-18.2%	-18.2%
1 Year	-20.3%	-20.3%

More News

Smith & Nephew SNATS Q2 Earnings Call Highlights ↗

August 09, 2026

Via MarketBeat

Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week

August 05, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith & Nephew plc (NYSE:SNN) Caviar Cruise Screen Analysis ↗

July 01, 2026

Via Chartmill

Smith & Nephew (NYSE:SNN) Qualifies as a Quality Investment Through the Caviar Cruise Screen ↗

April 24, 2026

Via Chartmill

Smith & Nephew PLC (NYSE:SNN) Passes the Caviar Cruise Screen for Quality Investing ↗

April 02, 2026

Via Chartmill

Smith & Nephew (SNN) Q2 2026 Earnings Call Transcript ↗

August 04, 2026

Via The Motley Fool

Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation

July 29, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care

July 21, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons

July 15, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus

June 09, 2026

From Equity Insider

Via GlobeNewswire

Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty

June 08, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact

June 01, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching

May 22, 2026

From World Street Intelligence

Via GlobeNewswire

Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026

May 05, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years

April 21, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,*

April 09, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention

March 10, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026

March 03, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026

March 02, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons

February 24, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew signs distribution agreement with SI-BONE

February 23, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair

January 21, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith & Nephew PLC (NYSE:SNN): A Value Investment in Medical Devices ↗

November 29, 2025

Via Chartmill

Frequently Asked Questions

Is Smith & Nephew SNATS, Inc. Common Stock publicly traded?

Yes, Smith & Nephew SNATS, Inc. Common Stock is publicly traded.

What exchange does Smith & Nephew SNATS, Inc. Common Stock trade on?

Smith & Nephew SNATS, Inc. Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Smith & Nephew SNATS, Inc. Common Stock?

The ticker symbol for Smith & Nephew SNATS, Inc. Common Stock is SNN on the New York Stock Exchange

What is the current price of Smith & Nephew SNATS, Inc. Common Stock?

The current price of Smith & Nephew SNATS, Inc. Common Stock is 29.62

When was Smith & Nephew SNATS, Inc. Common Stock last traded?

The last trade of Smith & Nephew SNATS, Inc. Common Stock was at 08/24/26 06:30 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.